Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
1 It is the first Health Canada approved treatment to support both chronic weight management and to reduce the risk of non-fatal MI
Also available in a stack save up to 169,00 Cell Renewal - Advancedsave 169,00 View the stack FOXO4-DRI - Selective Senescent Cell Disruption & Longevity Interferes with senescence survival pathways Restores apoptotic signaling Targets damaged cellular populations Influences inflammatory secretory phenotype Promotes removal of dysfunctional cells Studied in aging biology models Engages FOXO4-mediated pathways Supports regenerative research environments Description FOXO4-DRI is a modified peptide designed to interfere with the interaction between FOXO4 and p53 , a key protein involved in cellular stress responses
Each test is selected based on your unique presentation, goals, and risk profile, never a one-size-fits-all protocol
This label-based guidance removes guesswork from travel scheduling
US$ 27.17
US$ 27.71
US$ 29.01
